Mar 29, 2023
Do you know how to select the optimal treatment for a patient
with early breast cancer who is eligible for PARP inhibitor and
CDK4/6 inhibitor therapy?
Credit available for this activity expires: 3/29/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990176?ecd=bdc_podcast_libsyn_mscpedu